Suppr超能文献

人类口服剂量后d-苯丙胺的尿排泄:对尿液药物检测的影响。

Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing.

作者信息

Poklis A, Still J, Slattum P W, Edinboro L F, Saady J J, Costantino A

机构信息

Department of Pathology, Medical College of Virginia Campus at Virginia Commonwealth University, Richmond 23298-0165, USA.

出版信息

J Anal Toxicol. 1998 Oct;22(6):481-6. doi: 10.1093/jat/22.6.481.

Abstract

Seven healthy male volunteers received a single oral dose of 5 mg, 10 mg, or 20 mg of d-amphetamine. Urine was collected at 2, 4, 8, 12, 18, and 24 h post-dose. Total urine volume was measured, and pH and creatinine were determined. All specimens were analyzed by TDx Amphetamine/Methamphetamine II (TDx), Emit-d.a.u. Monoclonal Amphetamine/Methamphetamine (EM), and Emit II Amphetamine/Methamphetamine (EII) immunoassays at a cutoff value of 1000-ng/mL amphetamine. Quantitation of urinary amphetamine in all specimens was performed by gas chromatography-mass spectrometry. All urine testing results by the three immunoassays, EM, EII, and TDx, were in agreement; there were no discordant findings. Of the 42 total urine specimens collected following a 5-mg dose of amphetamine, only 8 (19%) screened positive by immunoassay. Twenty-four of 36 (67%) urine specimens yielded positive responses following a 10-mg dose, and 37 of 42 (88%) were positive by immunoassay following a 20-mg dose. These data demonstrate the present guideline for regulated forensic urine drug testing (FUDT) for amphetamine with a screening cutoff of 1000 ng/mL is too high to consistently detect the administration of a single 5-mg oral dose of d-amphetamine. There was considerable overlap of amphetamine concentrations in individual specimens following the various doses. Peak urinary amphetamine ranged from 620 to 3160 ng/mL following 5-mg doses. The time to peak concentration also varied widely at each dose, occurring in urines collected 2 to 18 h post-administration. The mean percent of dose excreted as unchanged amphetamine over 24 h at each dose ranged from 35 to 44%. The data demonstrated that amphetamine excretion increases with increasing urine flow and decreasing urine pH. Thus, a positive FUDT result for amphetamine means only that the individual was administered or self-administered amphetamine at some time prior to collection of the specimen.

摘要

七名健康男性志愿者单次口服5毫克、10毫克或20毫克的右旋苯丙胺。给药后2、4、8、12、18和24小时收集尿液。测量尿液总体积,并测定pH值和肌酐。所有标本均采用TDx苯丙胺/甲基苯丙胺II(TDx)、Emit-d.a.u.单克隆苯丙胺/甲基苯丙胺(EM)和Emit II苯丙胺/甲基苯丙胺(EII)免疫分析法进行分析,苯丙胺的截断值为1000纳克/毫升。所有标本中的尿苯丙胺定量采用气相色谱-质谱法进行。EM、EII和TDx这三种免疫分析法的所有尿液检测结果均一致;没有不一致的结果。在服用5毫克苯丙胺后收集的42份尿液标本中,只有8份(19%)通过免疫分析筛查呈阳性。在服用10毫克剂量后,36份尿液标本中的24份(67%)产生阳性反应,在服用20毫克剂量后,42份尿液标本中的37份(88%)通过免疫分析呈阳性。这些数据表明,目前苯丙胺受管制法医尿液药物检测(FUDT)的指导方针,筛查截断值为1000纳克/毫升,过高以至于无法始终检测出单次口服5毫克右旋苯丙胺的给药情况。不同剂量后个体标本中苯丙胺浓度有相当大的重叠。服用5毫克剂量后,尿苯丙胺峰值范围为每毫升620至3160纳克。每个剂量下达到峰值浓度的时间也有很大差异,出现在给药后2至18小时收集的尿液中。每个剂量下24小时内以未变化苯丙胺形式排泄的剂量平均百分比范围为35%至44%。数据表明,苯丙胺排泄量随着尿流量增加和尿液pH值降低而增加。因此,苯丙胺FUDT检测呈阳性仅意味着个体在采集标本之前的某个时间服用或自行服用了苯丙胺。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验